Navigation Links
Shengtai Pharmaceutical, Inc. Reports First Quarter Results of Fiscal Year 2008
Date:11/15/2007

WEIFANG, China, Nov. 15 /Xinhua-PRNewswire-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai Pharmaceutical" or "the Company"), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China, today reported financial results for the three months ended September 30, 2007.

First Quarter of Fiscal 2008 Highlights

-- Net sales increased 82.8% to $19.4 million

-- Gross profit rose 88.3% to $4.6 million

-- Gross profit margin was 23.7%

-- Operating income increased 97.4% to $2.9 million

-- Net income increased 51.8% to $2.3 million

-- Weighted avg. diluted shares outstanding were 18.9 million vs. 10.1

million

-- Fully diluted EPS was $0.11 versus $0.15

First Quarter of Fiscal 2008 Results

For the first quarter of fiscal 2008, net revenues increased 82.8% to $19.4 million from $10.6 million in the first quarter of fiscal 2007. This increase was largely due to increased sales of glucose and as well as higher product selling prices. In addition, sales of excess cornstarch produced from the Company's own cornstarch manufacturing facility and sold to customers comprised 31.2% of total revenue for the reporting period.

"We had a good start to our business operations for the fiscal year of 2008," said Chairman and CEO, Mr. Qingtai Liu. "Both our revenues and net income are growing dramatically due to strong market demand, and as we benefit from our strategy of becoming vertically integrated, to focus on achieving operating efficiencies and introducing higher-value products."

Gross profit for the three months ended September 30, 2007 was $4.6 million, an increase of 88.3% from $2.4 million for the same period of the prior year. Gross profit margin was 23.7%, a slight improvement from 2006. The improved gross profit was mostly due to economies of scale resulting from the expansion of production output and enhanced o
'/>"/>

SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Shengtai Pharmaceutical, Inc. Reports Record 2007 Annual Results
2. Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
3. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
4. Haemacure Reports Third Quarter 2007 Results
5. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
6. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
7. MDS Reports Third Quarter 2007 Results
8. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
11. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... September 04, 2015 , ... Keeping mold top of mind is important ... quite common. Mold can grow anywhere - on carpet, clothing, food, paper, and even ... moisture and water in the home is key to preventing mold growth, which if ...
(Date:9/4/2015)... ... September 04, 2015 , ... Bio-Logic Aqua® Research, a ... announced its only mission and research focus: Water Life Science®. In the current ... water evaporation is becoming dangerously accelerated. As a result of the global fresh ...
(Date:9/4/2015)... New York, NY (PRWEB) , ... September 04, 2015 , ... ... 400 meters qualifying heat, and followed up with victory in the men’s 400 meters ... Caribbean (NACAC) Senior Track and Field Championships in San Jose, Costa Rica in August ...
(Date:9/4/2015)... ... 04, 2015 , ... EMED Jamaica Global Ltd. (EMED), Jamaica’s ... entered into a multi-year agreement with Health City Cayman Islands. , ( http://www.healthcitycaymanislands.com ... American healthcare, Jamaican healthcare and Health City Cayman Islands to deliver high-quality, affordable ...
(Date:9/3/2015)... ... , ... TransPack Toon gives users a set of 90 cartoon transitions for ... in 30 different styles. Presets range from snow, underwater, forest, futuristic, city and many ... features 90 cartoon transitions from 30 unique styles. Editors can choose between line ...
Breaking Medicine News(10 mins):Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6Health News:Pixel Film Studios Releases TransPack Toon, a New FCPX Transition 2
... Shelves for Father,s Day , , NEW YORK, June 8 ... pain may lie in a $59.99 biomechanically-engineered foam and rubber flip-flop ... for the sixty million adults who reported persistent back pain last ... be a medical breakthrough is now available in the Dass, a ...
... , BALTIMORE, June 8 Metastorm, a leading provider ... and Enterprise Architecture (EA) software for aligning strategy with ... customer Wyeth Pharmaceuticals as one of this year,s CIO ... Wyeth is one of the world,s largest pharmaceutical and ...
... Factor Driving the Market Decline Will be Singulair,s Loss ... Decision Resources , , WALTHAM, Mass., June 8 ... and advisory firms for pharmaceutical and healthcare issues, finds ... and cost consciousness will reduce the asthma drug market ...
... Cedars-Sinai Outpatient Cancer Center Appointed COO , , ... today announced the appointment of Paul R. O,Dea to ... formerly Vice President, Aptium Oncology and Executive Director, Cedars-Sinai ... hospital-based cancer centers. The appointment was effective June 1, ...
... LOMBARD, Ill., June 8 A major session at the ... Conference will focus on how supply chains are helping to ... will be held September 20-23 in Chicago, Illinois. , ... improving delivery of drugs, vaccines, and other remedies to needy ...
... More Efficient Operation for Gateway Healthcare , , ... announced today that it is addressing the ... with the unique, next generation voice product, Cox ... moved its telecommunications services from a competitive provider to ...
Cached Medicine News:Health News:One of Women's Best Kept Secrets is Now Available in the Men's Department 2Health News:Metastorm Customer, Wyeth Pharmaceuticals, Wins CIO 100 Award for BPM Project 2Health News:Generic Erosion, Increased Competition and Cost Consciousness Will Reduce Overall Asthma Drug Market by $1.8 Billion from 2008 to 2018 2Health News:Aptium Oncology Names New Chief Operating Officer 2Health News:Cox Business Addresses Complex Voice Needs of Health Care Organization 2Health News:Cox Business Addresses Complex Voice Needs of Health Care Organization 3Health News:Cox Business Addresses Complex Voice Needs of Health Care Organization 4
(Date:9/4/2015)... PUNE, India , September 4, 2015 /PRNewswire/ ... Industry, 2015 Market Research Report is a professional ... the global Surgical Gown industry with a focus ... will take 2-3 working days once an order ... gown market spread across 150 pages, analyzing and ...
(Date:9/4/2015)... 4, 2015 According to a ... Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis) by Procedure (Therapeutic Apheresis, ... - Global Forecast to 2020", published by MarketsandMarkets, the ... Billion by 2020, growing at a CAGR of 11.2% ... Browse 139 Tables and 45 F ...
(Date:9/4/2015)...  Cumberland Pharmaceuticals (CPIX), today announced that A.J. Kazimi ... on September 10, 2015. DATE: Thursday, September ... http://tinyurl.com/sep10pre This will be a ... ask the company questions in real-time - both in ... trade booth." If attendees are not able to join ...
Breaking Medicine Technology:Surgical Gown Market 2020 Forecasts With a Focus on China 2Surgical Gown Market 2020 Forecasts With a Focus on China 3Surgical Gown Market 2020 Forecasts With a Focus on China 4Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com September 10 2
... - Phase 2 trial expected to begin in late ... June 4 Nuvelo, Inc.,(Nasdaq: NUVO ) today ... a,single-center, Phase 1b trial to determine the safety, tolerability ... direct,thrombin-inhibiting aptamer, in approximately 30 healthy male volunteers., ...
... at American Society of Clinical Oncology meeting indicate ... compared to historical data., PRINCETON, N.J., June ... CPX-1 Phase 2 clinical trial in patients,with advanced ... and floxuridine, based on the company,s proprietary,CombiPlex(TM) technology. ...
Cached Medicine Technology:Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172 2Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172 3Celator(R) Pharmaceuticals Announces Positive Phase 2 Results for CPX-1 in Treatment of Colorectal Cancer 2Celator(R) Pharmaceuticals Announces Positive Phase 2 Results for CPX-1 in Treatment of Colorectal Cancer 3
... a unique and versatile posterior spinal implant ... as a translational implant in correction of ... for bone or metallic implants, cables have ... configurations. Songer Cables offer advantages in strength, ...
Demineralized bone matrix dispensed in a jar. Fibers will be free of foreign matter. Glycerol 70-88% by weight. Calcium content less than 8%....
Demineralized bone matrix dispensed in a syringe. DBM will be free of foreign matter. Demineralized bone matrix particle size 125 to 850 . Glycerol 70-88% by weight. Calcium content less than 8%....
... matrix and conductive cancellous chips. ... be free of foreign matter. ... is 125 to 1000 . ... 1 - 8 mm. 5:3 ...
Medicine Products: